期刊文献+

头孢哌酮/舒巴坦对老年医院获得性肺炎的疗效分析 被引量:9

Curative effect analysis of cefoperazone/sulbactam in the treatment of senile Hospital-acquired pneumonia
下载PDF
导出
摘要 目的探讨头孢哌酮/舒巴坦对老年医院获得性肺炎(HAP)治疗效果。方法对我院收治的98例老年医院获得性肺炎患者随机分为实验组及对照组,实验组患者用头孢哌酮/舒巴坦进行治疗,对照组患者采用头孢哌酮进行治疗,治疗后对两组患者疗效以及细菌清除率进行比较。结果实验组患者的治疗效果以及致病菌的清除率明显优于对照组(P<0.05)。结论头孢哌酮/舒巴坦对老年医院获得性肺炎具有良好的治疗效果,致病菌对其耐药性低。 Objective To investigate the curative effect of cefoperazone/sulbactam in the treatment of senile Hospital-acquired pneumonia (HAP). Methods 98 cases of senile HAP in our hospital were randomly divided into experimental group and control group, meanwhile the control group treated with cefoperazone/sulbactam and the control group were treated with cefoperazone, and then the cura- tive effect and bacterial eradication rate were compared between the two groups after treatment. Results The curative effect and bacterial eradication rate in experimental group were significantly better than those in the control group ( P 〈 0.05 ). Conclusion cefoperazone/sulbactam in elderly hospital-acquired pneumonia with a good therapeutic effect, the low resistance of its pathogens, can effectively improve the prognosis of patients, and reduce patients' mortality.
出处 《临床肺科杂志》 2012年第3期400-402,共3页 Journal of Clinical Pulmonary Medicine
关键词 头孢哌酮/舒巴坦 医院获得性肺炎 老年 预后分析 cefoperazone/sulbactam hospital-acquired pneumonia elderly prognosis
  • 相关文献

参考文献8

  • 1Zhou Y,Zhang J,Guo B,et al.Liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of cefoperazone and sulbactam in plasma and its application to a pharmacokinetic study[J].J Chromatogr B Analyt Technol Biomed Life Sci,2010,878(30):3119-3124.
  • 2Kucukbayrak A,Ugurman F,Dereli N,et al.A community acquired pneumonia case caused by Ralstonia pickettii[J].Mikrobiyol Bul,2009,43(2):331-334.
  • 3马明.头孢哌酮舒巴坦钠对医院获得性肺炎21例疗效观察[J].中国现代药物应用,2008,2(14):65-65. 被引量:3
  • 4Kurz H,Gopfrich H:Epidemiology and morbidity of mycoplasma as causative agent for community-acquired pneumonia in hospitalized children in a Community Hospital in Vienna[J].Wien Med Wochenschr,2011,161(7-8):180-183.
  • 5El-Solh AA,Niederman MS,Drinka P.Nursing home-acquired pneumonia:a review of risk factors and therapeutic approaches[J].Curr Med Res Opin,2010,26(12):2707-2714.
  • 6王臻,童朝辉.头孢哌酮/舒巴坦在医院获得性肺炎治疗中的作用[J].中华医院感染学杂志,2006,16(5):595-596. 被引量:23
  • 7Giusti M,Banff F,Perrone F,et al.Community-acquired pneumonia:a budget impact model[J].Infez Med,2010,18(3):143-153.
  • 8Wispelwey B,Schafer KR.Fluoroquinolones in the management of community-acquired pneumonia in primary care[J].Expert Rev Anti Infect Ther,2010,8(11):1259-1271.

二级参考文献5

共引文献24

同被引文献58

引证文献9

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部